Table 1 (abstract P152). Extracorporeal support therapies and outcomes of patients.
From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)
| Â | Died(N=23) | Survivors(N=25) | p-value |
|---|---|---|---|
Mechanical ventilation1 | 22 (95,7) | 20 (80,0) | 0,19F |
Duration (days)2 | 13 (7-27) | 13 (6-23) | 0,67 |
ECMO1 | 5 (21,7) | 5 (20,0) | 1,0F |
Duration (days)2 | 25 (2-69) | 7 (6-7) | 0,63 |
CRRT1 | 17 (73,9) | 11 (44,0) | 0,036 C |
Plasma exchange1 | 8 (34,8) | 8 (32,0) | 0,84C |
CytoSorb1 | 3 (13,0) | 2 (8,0) | 0,66F |
Days in PICU2 | 30 (10-45) | 17 (9-30) | 0,13 |